Hi Shatter
Good to be on a more positive board - you know which one I mean!.
I am with Halifax as well and mine isn't in either; sometimes it isn't even the same day but it arrives eventually. I am on auto reinvest. Also have Lloyds and Barclays. Lloyds in profit; Barclays about £80p ps down.
Sale and leaseback isn't death spiral financing but it's hardly a sign of strength either and that's the way the market seems to have taken it reading the interims as no likelihood of profitability soon and cashflow problems.
In an acute dilemma as to whether to crystallise my large losses or hang on for a few more years, as that's as long as it's going to be imho
Hasn't caused any excitement in the market. Hard to know what to make of them despite the upbeat commentary though at least we are now clear that the AZ bonanza is over. In my (admittedly limited) experience - sale and leaseback is usually a method of raising capital at the expense of ongoing commitments so what does it mean here?
There appears to be a long way to go yet before it becomes profitable.
All my biotechs are suffering - Angle, SAR, VAL - and this is no exception.
Strummer.
I think you sum up well the dilemma we probably all have to stick or twist.
The main problem - already expressed by others so nothing original - is the lack of financial clarity. We all know that cashflow kills companies so if they had come out with we need more working capital of this amount to get us into this position and we are working out the best way between debt and equity then we would all know where we stand. But apart from Moon saying 50m we have no idea of the amount or even timescale. Is is 3 month down the line problem or next week for instance.
In a quandary.
A percentage dilution is the same regardless of the starting sp.
i.e if it is a 80% dilution on £5 it falls to £1 and on 5p it falls to 1p.
I am not invested but looking closely as there may be a spike before dilution occurs. Dont know what to do so will do nothing tonight.
GLA whatever you decide
I hope so though the previous appear to have done nothing for us; as the rns says "with this being the fifth new or expanded customer partnership we have announced this year" and look what has happened to the sp.
Still holding but probably more in hope than expectation. Will make a decision after the interims to stick or twist.
GLALTH
Yes which means we have no idea of the significance of this - is it substantial or peanuts - so it doesn't help shift the sp as we can see from the reaction.
Hopefully the interim will at least bring some clarity to the financial situation and be a bit forward looking but who knows.
Does anyone have any idea why this large drop?
Going ex div for 22p cant have done it
Hi Shatter
Good to know you are keeping an eye on us poor souls!
Interim in 3 weeks so some answers might emerge. This is what was said in April. Will we be as positive in September?
Total revenues increased by 63% over 2020 to £142.8 million (2020: £87.7 million).
· Revenues from bioprocessing and commercial development continued its upward trend, growing 87% due to large scale commercial manufacture of the Oxford AstraZeneca COVID-19 vaccine.
· Operating EBITDA1 and operating profits improved by £28.5 million and £26.5 million respectively, with the Group generating an Operating EBITDA1 profit of £35.9 million and an operating profit of £20.8 million.
Panama
Thanks for the considered and thoughtful reply - unlike a lot of the abusive ones on here.
Fwiw I am holding with an average of 5.5p so still in the blue but wishing my foresight was as good as my hindsight!
GLALTH
Panama
I am sure a lot of people, including me (though I fully accept I am totally responsible for my own decisions) did watch and listen to "sit on your hands" when it was at 38p and to "its a top up opportunity" every time it went down. I topped up at 24, 22, 20,18, 14.6 and now at 8.6 increasing my average substantially and I don't think I am alone. Watch, listen and learn from whom?
Cheers
Let's hope it goes better than Angle did when it got FDA approval recently. The sp nearly doubled to over 150p but then sank back to below the price before the announcement where it languishes now. people blames sellers into the rise and also because the approval doesn't mean that much will happen for a while plus some crass statement by the CEO. First bought IMM in 2013 in case anybody asks.